⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 18, 2024Open Access

Figure S3 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity

Priyanka S. Rana James J. Ignatz-Hoover Byung‐Gyu Kim Ehsan Malek Yuriy Federov Drew Adams Timothy A. Chan James J. Driscoll

View Full Paper

Ask AI

Bookmark

Share

Abstract

Fig. S3. Chemical structure of top pharmacologics identified in the HTS that increased proteasome ChT-like activity.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rana et al. (2024) studied this question.

synapsesocial.com/papers/68e64531b6db6435875d6983 https://doi.org/10.1158/2767-9764.26058197

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
2Table S1 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
3Table S2 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
4Table S2 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
5Figure S5 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024

More related papers

Table S4 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
Table S4 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024
Figure S1 from HDAC6 Inhibition Releases HR23B to Activate Proteasomes, Expand the Tumor Immunopeptidome and Amplify T-cell Antimyeloma Activity2024